Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Maravai LifeSciences Holdings, Inc. - Class A common stock
(NQ:
MRVI
)
3.250
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 12, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Maravai LifeSciences Holdings, Inc. - Class A common stock
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Maravai LifeSciences Announces November 2025 Investor Conference Schedule
November 10, 2025
From
Maravai LifeSciences, Inc.
Via
Business Wire
Maravai LifeSciences (MRVI) Stock Plummets After Q3 2025 Revenue Miss and Weak Guidance
↗
November 06, 2025
Maravai LifeSciences (MRVI) stock fell after Q3 2025 revenue missed estimates. The company reported a net loss and provided full-year guidance below analyst expectations.
Via
Chartmill
Maravai LifeSciences Reports Third Quarter 2025 Financial Results
November 06, 2025
From
Maravai LifeSciences Holdings, Inc.
Via
Business Wire
Earnings Scheduled For November 6, 2025
↗
November 06, 2025
Via
Benzinga
MARAVAI INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Continues Investigation on Behalf of Maravai Long-Term Stockholders
October 29, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
What to Expect from Maravai LifeSciences's Earnings
↗
August 08, 2025
Via
Benzinga
Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 6, 2025
October 22, 2025
From
Maravai LifeSciences, Inc.
Via
Business Wire
MARAVAI (MRVI) INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Reminds Investors of the Investigation into Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
October 02, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
MARAVAI INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
September 09, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
Earnings Scheduled For May 12, 2025
↗
May 12, 2025
Via
Benzinga
Maravai LifeSciences Reports Second Quarter 2025 Financial Results
August 11, 2025
From
Maravai LifeSciences Holdings LLC
Via
GlobeNewswire
Beyond the Headlines: A Look at Today's Key Corporate Earnings Reports
August 11, 2025
Today, August 11, 2025, marks a significant day for investors looking beyond the typical S&P 500 giants, as a diverse array of companies across various sectors unveiled their latest quarterly earnings....
Via
MarketMinute
Topics
Economy
Stocks
Maravai LifeSciences To Host Earnings Conference Call on Monday, August 11, 2025
July 28, 2025
From
Maravai LifeSciences Holdings LLC
Via
GlobeNewswire
Earnings Scheduled For August 11, 2025
↗
August 11, 2025
Via
Benzinga
MARAVAI LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Maravai LifeSciences Holdings, Inc. - MRVI
July 25, 2025
From
Kahn Swick & Foti, LLC
Via
Business Wire
MARAVAI INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
July 22, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
MARAVAI ALERT: Bragar Eagel & Squire, P.C. is Investigating Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
July 14, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
MARAVAI ALERT: Bragar Eagel & Squire, P.C. is Investigating Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
July 08, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
MARAVAI LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Maravai LifeSciences Holdings, Inc. - MRVI
June 27, 2025
From
Kahn Swick & Foti, LLC
Via
Business Wire
Maravai LifeSciences Appoints Rajesh Asarpota as Chief Financial Officer
June 25, 2025
From
Maravai LifeSciences Holdings LLC
Via
GlobeNewswire
Maravai ALERT: Bragar Eagel & Squire, P.C. is Investigating Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
June 24, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
Maravai LifeSciences Appoints Bernd Brust as Chief Executive Officer and Member of its Board of Directors
June 09, 2025
From
Maravai LifeSciences Holdings LLC
Via
GlobeNewswire
TriLink BioTechnologies® and Quantoom Biosciences Sign License and Supply Agreement for CleanCap® mRNA Capping Technology
June 03, 2025
From
TriLink BioTechnologies
Via
Business Wire
CORRECTION – Maravai LifeSciences Releases 2024 Sustainability Report
May 21, 2025
From
Maravai LifeSciences Holdings LLC
Via
GlobeNewswire
Maravai LifeSciencesReleases 2024 Sustainability Report
May 21, 2025
From
Maravai LifeSciences Holdings LLC
Via
GlobeNewswire
TriLink BioTechnologies® debuts its first mRNA synthesis kit with CleanCap® capping technology; Celebrates launch with kit donations to top academic institutions
May 20, 2025
From
TriLink BioTechnologies
Via
Business Wire
TriLink BioTechnologies® and the International Vaccine Institute Sign a Memorandum of Understanding to Support the Development of mRNA-based Vaccines
May 14, 2025
From
TriLink BioTechnologies
Via
Business Wire
These Analysts Slash Their Forecasts On Maravai LifeSciences Following Q1 Results
↗
May 13, 2025
Via
Benzinga
Assessing Maravai LifeSciences: Insights From 5 Financial Analysts
↗
May 13, 2025
Via
Benzinga
Maravai Lifesciences Reports First Quarter 2025 Financial Results
May 12, 2025
From
Maravai LifeSciences Holdings LLC
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.